'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of T-Cell Lymphomas to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of T-Cell Lymphomas to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in T-Cell Lymphomas Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on T-Cell Lymphomas 36
Jun 13, 2018: CStone Pharmaceuticals Initiates Two Pivotal Phase II Studies of the Anti-PD-L1 Monoclonal Antibody CS1001 36
Clinical Trial Profile Snapshots 37
Appendix 774
Abbreviations 774
Definitions 774
Research Methodology 775
Secondary Research 775
About GlobalData 775
Contact Us 776
Disclaimer 776
Source 776
List of Tables
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region, 2018* 7
T-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2018* 16
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2018* 20
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase, 2018* 24
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
T-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
List of Figures
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
T-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2018* 16
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2018* 20
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
T-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
GlobalData Methodology 775
